Catalyst Pharmaceutical Partners Inc buy Oppenheimer Holdings Inc.
Start price
07.11.25
/
50%
€19.04
Target price
07.11.26
-
Performance (%)
17.68%
Price
17.04.26
€22.40
Summary
This prediction is currently active. The prediction currently has a performance of 17.68%. This prediction currently runs until 07.11.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 5.164% | 5.164% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.48
06.06.24
06.06.24
€26.64
06.06.25
06.06.25
58.84%
07.06.25
07.06.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€15.07
27.03.24
27.03.24
€26.80
27.03.25
27.03.25
48.95%
28.03.25
28.03.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.09
21.12.23
21.12.23
€27.29
21.12.24
21.12.24
43.08%
22.12.24
22.12.24